Valeo Financial Advisors’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-4,082
| Closed | -$328K | – | 1270 |
|
|
2021
Q1 | $328K | Sell |
4,082
-5,000
| -55% | -$402K | 0.02% | 333 |
|
|
2020
Q4 | $494K | Hold |
9,082
| – | – | 0.03% | 246 |
|
|
2020
Q3 | $181K | Hold |
9,082
| – | – | 0.02% | 338 |
|
|
2020
Q2 | $191K | Buy |
9,082
+8,311
| +1,078% | +$175K | 0.02% | 323 |
|
|
2020
Q1 | $10K | Hold |
771
| – | – | ﹤0.01% | 1057 |
|
|
2019
Q4 | $11K | Hold |
771
| – | – | ﹤0.01% | 1077 |
|
|
2019
Q3 | $10K | Hold |
771
| – | – | ﹤0.01% | 1015 |
|
|
2019
Q2 | $13K | Hold |
771
| – | – | ﹤0.01% | 959 |
|
|
2019
Q1 | $13K | Buy |
771
+609
| +376% | +$10.3K | ﹤0.01% | 893 |
|
|
2018
Q4 | $2K | Hold |
162
| – | – | ﹤0.01% | 1291 |
|
|
2018
Q3 | $3K | Buy |
162
+82
| +103% | +$1.52K | ﹤0.01% | 1356 |
|
|
2018
Q2 | $2K | Hold |
80
| – | – | ﹤0.01% | 1355 |
|
|
2018
Q1 | $2K | Hold |
80
| – | – | ﹤0.01% | 1337 |
|
|
2017
Q4 | $2K | Hold |
80
| – | – | ﹤0.01% | 1190 |
|
|
2017
Q3 | $2K | Buy |
+80
| New | +$2K | ﹤0.01% | 1026 |
|